Evidence map›Paper›PMID 35346897›Full record

ArticleJournal of gynecology obstetrics and human reproduction2022

Impact of COVID-19 infection in pregnancy and neonates: A case control study.

Camille Daclin, Marie Carbonnel, Manon Rossignol, Hind Abbou, Hela Trabelsi, Aminata Cimmino, Justine Delmas, Anne-Sophie Rifai, Lou-Andréa Coiquaud, Audrey Tiberon and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gynecology obstetrics and human reproduction, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Maternal and neonatal outcomes in women with COVID-19: A retrospective cohort study.International journal of reproductive biomedicine · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Camille DaclinDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Marie CarbonnelDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France. Electronic address: m.carbonnel@hopital-foch.com.
Manon RossignolDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Hind AbbouDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Hela TrabelsiDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Aminata CimminoDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Justine DelmasDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Anne-Sophie RifaiDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Lou-Andréa CoiquaudDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Audrey TiberonDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Morgan Le GuenDepartment of Anesthesiology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Jean-Marc AyoubiDepartment of Obstetrics and Gynecology, Hospital Foch, 40, rue Worth, Suresnes, 92150 and University of Versailles, Saint-Quentin-en-Yvelines, 55, avenue de Paris, 78000 Versailles, France.
Université de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate maternal and neonatal outcomes of pregnant women who were infected by COVID-19 during pregnancy. STUDY

designA Case control retrospective study was conducted in an Obstetrical Department of a west Parisian area during the first year of COVID-19 pandemic. Maternal and neonatal outcomes were compared between a group of women infected by the SARS-CoV-2 virus during pregnancy (March 2020- February 2021) and a control group of women delivering before pandemic. They were matched according to age and parity. Subgroups of SARS-CoV-2 infection occurring before vs after 37 weeks of gestations and symptomatic vs asymptomatic patients were analyzed. The rate of preterm birth, preeclampsia, placental abruption and stillbirth were compared between the year of pandemic and the year before for all deliveries.

resultsMaternal and neonatal outcomes were similar. Among the 86 pregnant women with SARS-CoV-2 infection, five were admitted to Hospital (5.8%). One was transferred in intensive care unit for respiratory distress (1.2%). All patients had favorable outcomes. Patients with symptoms had more associated comorbidities (34.5%, n = 20/58, with symptoms, vs 9,1%, n = 2/22, without symptoms, p = 0.023). No differences in preeclampsia, placenta abruption and stillbirth, but less preterm births (4.9%, n = 160/3383 vs 6.2%, n = 209/3235, p = 0.04) were observed between the year of pandemic and the year before.

conclusionThere were few complications associated with COVID-19 infection among pregnant patients and their neonates. A low rate of associated comorbidities, a good access to healthcare services in this area and the small sample size of patients could explain these results.

Indexed as

COVID-19Pre-EclampsiaPregnancy Complications, InfectiousPremature BirthCase-Control StudiesFemaleHumansInfant, NewbornPandemicsPlacentaPregnancyRetrospective StudiesSARS-CoV-2StillbirthComplications ABBREVIATIONS BMI, Body mass indexCOVID-19, infectionICU, intensive care unitNeonatal outcomesNICU, neonatal intensive care unitPregnancySD, standard deviationWG, weeks of gestation

Identifiers

PMID35346897
PMCPMC8949840
OpenAlexW4220726025

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.